Veenat 100 Mg (Imatinib)

✅ Key Benefits

• Highly targeted mechanism for precise cancer treatment

• Clinically validated to increase remission and survival rates

• Convenient once-daily oral therapy, eliminating need for infusion

• Flexible dosing support from 100 mg tablets to tailor therapy

• Well-established safety profile for long-term use

🎯 How to Use

• Recommended starting dose: 100 mg once daily, with adjustments based on disease type, response, and tolerance

• Take tablet whole with a glass of water, with or without food

• Continue until disease progresses or adverse effects require change

• Regular monitoring: complete blood counts (CBC), liver/renal tests, and cardiac evaluation

• Doctors may modify dosage or pause treatment based on lab results or side effects

⚠️ Precautions

• Prescription-only; supervised by an oncology specialist

• Watch for fluid retention, hepatotoxicity, and bone marrow suppression

• Cardiac monitoring is advised due to rare cardiomyopathy risk

• Use effective contraception during treatment and for months afterward

• Evaluate for drug interactions, especially with CYP3A4 substrates or inhibitors

🤕 Possible Side Effects

• Common: Edema, nausea, diarrhea, muscle cramps, fatigue

• Blood-related: Neutropenia, thrombocytopenia, anemia

• Liver-related: Elevated liver enzymes; rare jaundice

• Cardiac: Rare heart failure or cardiomyopathy

• Other: Skin rash, headache, fever

❓ Frequently Asked Questions (FAQs)

Q. Who is Veenat prescribed for?
A. Patients diagnosed with CML, Ph+ ALL, or c‑KIT positive GIST, under oncologist supervision.

Q. How long should treatment continue?
A. Typically maintained indefinitely while disease is controlled and side effects are manageable.

Q. Can I take it with meals?
A. Yes, consistently with or without food—pick the same daily routine.

Q. What safety monitoring is required?
A. Regular blood counts, liver and kidney tests, and occasional cardiac check-ups ensure safe therapy.